VADDI KRISHNA (President, CEO) purchased 8.4% of their position (97.50K shares) of PRELUDE THERAPEUTICS INC on the open market
Open‑market purchase worth $69.6K — a moderate purchase. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 3/14/2025ACC: 0001562180-25-002392
DirectorOfficer· President, CEO
Since Sep 2020
+97.50K
Net shares
Net buyer
$69.6K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
97.50K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+47.50K
Price / share
$0.71
Trade value
$33.74K
% of position
4.1%
3/12/2025
1.17M→1.21M
Common Stock
Direct
Shares
+50K
Price / share
$0.72
Trade value
$35.82K
% of position
4.1%
3/13/2025
1.21M→1.26M
Total
Net shares
+97.50K
Net value
$69.56K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/12/2025 | P · Purchase | +47.50K | $0.71 | $33.74K | 4.1% | 1.17M | 1.21M |
| Common Stock Direct | 3/13/2025 | P · Purchase | +50K | $0.72 | $35.82K | 4.1% | 1.21M | 1.26M |
| Total | +97.50K | $69.56K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned551.78K
Common Stock
IndirectShares owned551.77K
Common Stock
IndirectShares owned423.65K
Common Stock
IndirectShares owned142.55K
Total
1.67M indirect1.67M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 551.78K | Indirect |
| Common Stock | 551.77K | Indirect |
| Common Stock | 423.65K | Indirect |
| Common Stock | 142.55K | Indirect |
| Total | 1.67M | 1.67M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported